How to reduce nephropathy following contrast-enhanced CT: a lesson in policy implementation.
In excess of 50 contrast-enhanced computed tomography (CT) examinations are typically undertaken in our tertiary hospital NHS Trust each weekday, approximately 13,000 each year. In the Department of Radiology alone, we inject more than 1300 l of iodinated contrast medium per annum. There is a real need to devise a policy to anticipate contrast medium-induced nephropathy (CIN) and minimize its effects, without disrupting the high-intensity CT service. Having written a comprehensive yet pragmatic policy to reduce the incidence of this iatrogenic condition, it seemed sensible to share it with the wider radiology community and share the experience and lessons learnt in engaging all the stakeholders, ushering in the change with as little fuss as possible. The ramifications on primary and secondary care had to be anticipated, resource implications managed, and staff trained. This review is therefore presented in four sections: framing the problem, assessing its size and nature; a succeeding section on the available guidelines and their uptake; the policy itself to reduce CIN in CT is presented in the third section; and crucially, a description of the policy introduction process in the last section.
Radiology Department, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK. Jonathan.Richenberg@bsuh.nhs.uk
J
J
Richenberg
D002985:Clinical Protocols; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D016134:Organizational Policy; D018570:Risk Assessment; D012307:Risk Factors; D062606:Tertiary Care Centers; D014057:Tomography, X-Ray Computed; D006113:United Kingdom / Q000453:epidemiology
D003287:Contrast Media